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Dear Editor,
Establishment of an intraocular lymphoma may form a
diagnostic challenge, especially when biopsy is contraindi-
cated due to the anatomic site of the lesion. In recent years,
vitreous IL-10 levels above 400 pg/mL (sensitivity 80 %,
specificity 99 %) and a vitreous IL-10 to IL-6 ratio greater
than 1.0 (sensitivity 74 %, specificity 75 %) were found to be
associated with the presence of an intraocular lymphoma [1,
2]. We present a case where retinal biopsy was not possible.
A 45-year-old female with a history of lupus nephri-
tis class V presented with panuveitis of her right eye
and loss of visual acuity of both eyes. During fundo-
scopy, a slightly elevated lesion was observed (Fig. 1a).
As there was no systemic activity of her lupus eryth-
ematosus and the patient was immunocompromised due
to chronic use of azathioprine and prednisolone, oppor-
tunistic infections were considered. No Herpes Simplex
Virus, Varicella Zoster Virus, Cytomegalovirus, Epstein
–Barr virus, toxoplasmosis, borreliosis, syphilis, or
tuberculosis were found. Vitrectomy, however, revealed
a rapidly growing lesion involving the macula lutea
(Fig. 1b–c). Vitreous fluid analysis showed atypical
lymphocytes and an interleukin-10 to interleukin-6 ratio
of 14.8 (3,700 and 250 pg/mL, respectively), indicative
of lymphoma rather than a non-neoplastic cause of
uveitis. Brain magnetic resonance imaging, bone mar-
row, and spinal fluid analysis showed no abnormalities.
Histology of the primary tumor could not be obtained
as biopsy of this area would result in blindness. The
patient was diagnosed with a solitary intraocular lym-
phoma and was treated with 2 cycles of intravenous
methotrexate (3 g/m2, days 1 and 15); BCNU (100 mg/
m2, day 4); teniposide (100 mg/m2, days 2–3); prednis-
olone (60 mg/m2, days 1–5); and intrathecal methotrex-
ate, cytarabine, and hydrocortisone (15 mg, 40 mg, and
25 mg, respectively, days 1 and 15). The visual acuity
of both eyes improved during treatment, suggesting a
shrinking mass in both eyes. As there were no visible
lesions in the left eye, only the right eye was irradiated
(30 Gy). Six months later, the patient developed a
lesion consistent with an intraocular lymphoma in the
left eye, and at this time, radiotherapy was initiated for
the left eye. Up-to-date, almost 2 years later, fundo-
scopy only shows flat scars, and the patient has no
signs of ocular, cerebral, or systemic relapse (Fig. 1d).
Although high IL-10 levels are not pathognomonic
for an intraocular lymphoma, patients with suspect
lesions in regions which are essential for vision may
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benefit from vitreous interleukin measurement. If, in this
way, a retinal biopsy can be avoided, eyesight can be
retained. Furthermore, in patients presenting with a uni-
lateral intraocular lymphoma, irradiation of the contra-
lateral eye should be considered as up to 80 % actually
have bilateral disease [3].
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Fig. 1 Fundoscopic images of the right eye of a 45-year-old female. a
Uveitis and an underlying whitish, slightly elevated lesion. b Lesion
after vitrectomy, 12 weeks later. c Autofluorescent image postvitrec-
tomy. d Flat scar without signs of relapse, almost 2 years after chemo-
therapeutic treatment and irradiation
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